Macrophage-Derived Exosomes as Advanced Therapeutics for Inflammation: Current Progress and Future Perspectives

Yanjuan Song,Jing Hu,Chunlian Ma,Hua Liu,Zhanghua Li,Yi Yang
DOI: https://doi.org/10.2147/ijn.s449388
IF: 7.033
2024-02-19
International Journal of Nanomedicine
Abstract:Yanjuan Song, 1 Jing Hu, 2 Chunlian Ma, 3– 5 Hua Liu, 3– 5 Zhanghua Li, 6 Yi Yang 3– 5 1 Graduate School, Wuhan Sports University, Wuhan, Hubei Province, People's Republic of China; 2 Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei Province, People's Republic of China; 3 Fitness Monitoring and Chronic Disease Intervention Research Center, Wuhan Sports University, Wuhan, Hubei Province, People's Republic of China; 4 College of Sports Medicine, Wuhan Sports University, Wuhan, Hubei Province, People's Republic of China; 5 Hubei Key Laboratory of Exercise Training and Monitoring, Wuhan Sports University, Wuhan, Hubei Province, People's Republic of China; 6 Department of Orthopedics, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei Province, People's Republic of China Correspondence: Yi Yang, Fitness Monitoring and Chronic Disease Intervention research center, Wuhan Sports University, Wuhan, Hubei Province, 430079, People's Republic of China, Tel +86 139 7129 3990, Email Zhanghua Li, Department of Orthopedics, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei Province, 430074, People's Republic of China, Tel +86 189 7161 0121, Email The development of numerous diseases is significantly influenced by inflammation. Macrophage-derived exosomes (M-Exos) play a role in controlling inflammatory reactions in various conditions, including chronic inflammatory pain, hypertension, and diabetes. However, the specific targets and roles of M-Exos in regulating inflammation in diseases remain largely unknown. This review summarizes current knowledge on M-Exos biogenesis and provides updated information on M-Exos' biological function in inflammation modulation. Furthermore, this review highlights the functionalization and engineering strategies of M-Exos, while providing an overview of cutting-edge approaches to engineering M-Exos and advancements in their application as therapeutics for inflammation modulation. Finally, multiple engineering strategies and mechanisms are presented in this review along with their perspectives and challenges, and the potential contribution that M-Exos may have in diseases through the modulation of inflammation is discussed. Keywords: inflammation, macrophage-derived exosomes, biological functions, inflammation modulation, engineering strategies Inflammation is a natural biological response dominated by defense in local tissues to stimulation by pathogens, injured cells, chemicals, or physical trauma, the cardinal symptoms of which are typically characterized by redness, swelling, heat, pain, and dysfunction. 1 Inflammation can maintain homeostasis by repairing damaged tissues and organ function, increasing the number of leukocytes, and enhancing metabolism. 2,3 If inflammation is not promptly addressed, it will lead to a series of chronic inflammatory diseases (eg, diabetes, rheumatoid arthritis, cancer, inflammatory bowel diseases (IBD), cardiovascular disease, and neurologic system disorders). 4–6 Conventional drugs approaches to inflammation include steroids, glucocorticoids, nonsteroidal anti-inflammatory drugs or inhibitors targeting specific pro-inflammatory cytokines. 4,7,8 However, the aforementioned medicines have limited effect on inflammation regulation and cannot completely prevent disease progression. In addition, long-term administration of these medications can cause gastrointestinal adverse effects (eg nausea, vomiting) and osteoporosis, hyperglycemia. 9–11 Therefore, promising treatment approaches with durable efficacy and few side effects are urgently needed. Exosomes, which are nanosized vesicles derived from endocytosis, contain bioactive molecules such as proteins, DNA, and RNA. 12 These vesicles play a crucial role in facilitating material exchange between cells and participate in numerous physiological and pathological processes within the body. 13,14 With the deepening of research on exosomes, a high volume of evidence indicated that exosomes are involved in the regulation of inflammation and different types of inflammatory diseases as mediators and potential therapeutic targets. 15 This makes exosomes a promising candidate for inflammation. Macrophages are generally thought to be terminally differentiated immune cells that develop from monocytes, which originate from hematopoietic stem cells in the bone marrow. 16 After undergoing differentiation steps, monocytes enter the peripheral blood and become circulating monocytes, including inflammatory and resident monocytes. 17 After migrating to tissues, they differentiate into tissue-speci -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology
What problem does this paper attempt to address?